Title : FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension.

Pub. Date : 2013 Aug

PMID : 23867624






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The best response was achieved with FK506 (tacrolimus), via a dual mechanism of action as a calcineurin inhibitor that also binds FK-binding protein-12 (FKBP12), a repressor of BMP signaling. Tacrolimus FKBP prolyl isomerase 1A Rattus norvegicus
2 The best response was achieved with FK506 (tacrolimus), via a dual mechanism of action as a calcineurin inhibitor that also binds FK-binding protein-12 (FKBP12), a repressor of BMP signaling. Tacrolimus FKBP prolyl isomerase 1A Rattus norvegicus
3 The best response was achieved with FK506 (tacrolimus), via a dual mechanism of action as a calcineurin inhibitor that also binds FK-binding protein-12 (FKBP12), a repressor of BMP signaling. Tacrolimus FKBP prolyl isomerase 1A Rattus norvegicus
4 The best response was achieved with FK506 (tacrolimus), via a dual mechanism of action as a calcineurin inhibitor that also binds FK-binding protein-12 (FKBP12), a repressor of BMP signaling. Tacrolimus FKBP prolyl isomerase 1A Rattus norvegicus
5 FK506 released FKBP12 from type I receptors activin receptor-like kinase 1 (ALK1), ALK2, and ALK3 and activated downstream SMAD1/5 and MAPK signaling and ID1 gene regulation in a manner superior to the calcineurin inhibitor cyclosporine and the FKBP12 ligand rapamycin. Tacrolimus FKBP prolyl isomerase 1A Rattus norvegicus
6 FK506 released FKBP12 from type I receptors activin receptor-like kinase 1 (ALK1), ALK2, and ALK3 and activated downstream SMAD1/5 and MAPK signaling and ID1 gene regulation in a manner superior to the calcineurin inhibitor cyclosporine and the FKBP12 ligand rapamycin. Tacrolimus FKBP prolyl isomerase 1A Rattus norvegicus